Press Releases | Medtronic

Month Year

Email alerts

Dec 7, 2016

Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management

New iPro(TM)2 myLog App Collects Data from Continuous Glucose Monitors (CGM) and Fitbit Activity Trackers, Provides Meaningful Insights on How Exercise Impacts Glucose Levels

DUBLIN and SAN FRANCISCO - Dec. 7, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and Fitbit (NYSE: FIT), the leader in the connected health and fitness market,...
Dec 6, 2016

Medtronic's Endurant(TM) II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique

Medtronic is First and Only Company to Receive Approval for a ChEVAR Indication, Providing an Off-the-Shelf Option for Patients with Complex Aneurysms

DUBLIN – Dec. 6, 2016 – Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the Endurant™ II/IIs stent graft system to treat abdominal aortic...
Dec 1, 2016

Medtronic Announces Reimbursement Approval and Launch of CoreValve(TM) Evolut(TM) R System in Japan

Medtronic Introduces First-and-Only Recapturable TAVI System Available in Japan

DUBLIN - Dec. 1, 2016 - Medtronic plc (NYSE: MDT) today announced it has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the recapturable,...
Nov 29, 2016

Medtronic First to Receive European Approval for Less-Invasive HVAD® Implant Procedure

New Implant Option Gives Physicians Surgical Alternative for Patients with Advanced Heart Failure

DUBLIN - Nov. 29, 2016 - Medtronic plc (NYSE: MDT) today announced that its HVAD® System left ventricular assist device (LVAD) received CE (Conformité Européenne) Mark for a less-invasive...
Nov 29, 2016

Medtronic Announces U.S. Launch of Integrated Health Solutions with University Hospitals Agreement

New Agreement Focuses on Improved System Efficiency at University Hospitals Cleveland Medical Center

DUBLIN and CLEVELAND - Nov. 29, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the signing of its first Integrated Health Solutions agreement in the...
Nov 22, 2016

Medtronic Reports Second Quarter Financial Results

Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency

DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
Nov 17, 2016

New Data Show Medtronic Heli-FX EndoAnchor System Enhances Outcomes and Durability in Complex Aortic Disease

Data from ANCHOR Registry Demonstrate Applicability in Patients with Hostile Aortic Neck Anatomy

DUBLIN and NEW YORK - Nov. 17, 2016 - Medtronic plc (NYSE: MDT) today announced data demonstrating that the company's Heli-FX(TM) EndoAnchor(TM) system enhances outcomes and durability in patients...
Nov 16, 2016

Medtronic's Solitaire(TM) Stent Retriever Device Receives Expanded Indication from the U.S. Food and Drug Administration for the Reduction of Stroke-Related Disability

FDA Allows Use of the Most Studied Stent Retriever with IV-tPA

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire(TM) stent retriever device....
Nov 16, 2016

Medtronic Releases FY16 Integrated Performance Report

Report Highlights Company's Global Financial, Social, and Environmental Impact

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and...
Nov 15, 2016

Medtronic's Endurant(TM) II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms

New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies

DUBLIN - Nov. 15, 2016 - Medtronic plc (NYSE:MDT) today announced data supporting the strength and durability of the Endurant(TM) II/IIs1 stent graft system to treat abdominal aortic aneurysm...

Show per page